Human Herpes Virus 6 in human epilepsy: Data from surgical resections

and their dynamic changes roughly paralleled the clinical course of EAN. Compound 1, a synthetic compound that can specifically block the production of Th17 cells, suppressed the severity of EAN symptoms when it was administered from the immunization day. However, Compound 1 was incapable of obviously affecting the clinical signs of EAN when administered after the onset of EAN. In conclusion, Th17 cells are a neuritogenic T helper cell subset in GBS and EAN.